Prof Vineet Ahuja, MD
Gastroenterology — All India Institute of Medical Sciences, India
Vineet Ahuja
LeadR Profile
Gastroenterology
Subspecialties: Hepatology - Infectiology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 586
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Celiac Disease: Waiting to Explode in Asia. liver diseases, glutens, celiac disease | J Gastroenterol Hepatol | 2026 | 0 |
| TREAT-TO-TARGET IN INFLAMMATORY BOWEL DISEASE: PROMISE, PERILS, AND THE PATH FORWARD. inflammatory bowel diseases, therapeutics | Clin Gastroenterol Hepatol | 2026 | 0 |
| Development and Prospective Validation of a Machine Learning-Based Mobile Application (CROHN'S AID) for Differentiating Crohn's Disease From Intestinal Tuberculosis in Tuberculosis-Endemic Regions. diagnosis, differential, crohn disease, machine learning, pharmacology, tuberculosis, mobile applications, therapeutics, learning, artificial intelligence, digital health | Aliment Pharmacol Ther | 2026 | 1 |
| Microbial dysbiosis and predictive neuroactive functional profiles in paediatric neurogenic bladder: an exploratory machine learning-based approach. dysbiosis, urinary bladder, coenzymes, genes, genes, rrna, urinary tract, amino acids, urinary bladder, neurogenic, classification, machine learning, cell biology, learning, child, phospholipids | Front Cell Infect Microbiol | 2026 | 0 |
| Revisiting the Role of Helicobacter Pylori in Immune Thrombocytopenia: Insights from a Tertiary Care Centre in India. helicobacter pylori, helicobacter, therapeutics, tertiary healthcare, thrombocytopenia, infections, purpura, thrombocytopenic, idiopathic | Indian J Hematol Blood Transfus | 2025 | 1 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis NCT07415044 — colitis, safety, program development, therapeutics, colitis, ulcerative | Phase 2 | Recruiting | 2026 |
| LY4268989 (MORF 057) Co Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis NCT07186101 — colitis, colitis, ulcerative | Phase 2 | Recruiting | 2025 |
| A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease NCT06890650 — fecal microbiota transplantation, crohn disease, cohort studies, diet, maintenance, probiotics, transplants, therapeutics, colonoscopy, transplantation, enteral nutrition, microbiota | N/A | Recruiting | 2025 |
| A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies NCT06890637 — fecal microbiota transplantation, crohn disease, multiple chronic conditions, diet, transplants, therapeutics, random allocation, colonoscopy, transplantation, microbiota, small molecules | N/A | Recruiting | 2025 |
| A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis NCT06895252 — anti-inflammatory agents, colitis, fecal microbiota transplantation, aminosalicylic acid, mesalamine, ulcer, diet, maintenance, transplants, therapeutics, colonoscopy, transplantation, colitis, ulcerative, microbiota | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map